Navigation Links
Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement
Date:10/4/2011

SAN DIEGO, Oct. 4, 2011 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that it has achieved its second milestone in its collaboration with Abbott for elagolix and next-generation Gonadotropin Releasing Hormone (GnRH) Receptor Antagonists. The Company and Abbott held a pre- phase III meeting with the FDA, the outcome of which generated a $20 million milestone payment from Abbott to the Company. This milestone event brings the total milestones achieved by the Company in the third quarter of 2011 to $30 million.

"This represents another significant step forward for the elagolix program as it readies for pivotal studies and we remain confident that Abbott has the right resources devoted to elagolix to enable it to be both a clinical and commercial success," said Kevin C. Gorman, President and Chief Executive Officer of Neurocrine Biosciences.

Endometriosis is associated with a multitude of symptoms, some of the most common of which include pain related both to menstruation (dysmenorrhea) as well as chronic pelvic pain throughout the menstrual cycle, and infertility. The World Endometriosis Research Foundation estimates that there are over 170 million women worldwide who suffer from endometriosis.

About Neurocrine Biosciences

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

In addition to historica
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
2. Neurocrine Biosciences Reports First Quarter 2008 Results
3. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
4. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
5. Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain
6. Neurocrine Biosciences Presents Elagolix Data
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
8. Neurocrine Biosciences Reports Third Quarter 2009 Results
9. Neurocrine Advances VMAT2 Inhibitor Program
10. Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
11. Neurocrine Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015 The Assistance Fund ... This program provides financial assistance for copay to individuals ... to announce the addition of the Melanoma Copay Assistance ... Mark McGreevy , executive director. "With each additional program ... of a world where no one is denied access ...
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. ... tissue protection, repair and regeneration, today announced that ... scheduled to present a corporate overview at two upcoming ... at the SeeThruEquity 4 th Annual Microcap Conference ... York City at 11:00 am EDT.  A ...
(Date:5/22/2015)...  The Mesothelioma Victims Center is incredibly passionate ... the best possible compensation, and they are also extremely ... cancer caused by exposure to asbestos or their ... treatment options such as a recent possible medical breakthrough. ... Center anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
Breaking Medicine Technology:The Assistance Fund Adds Melanoma Assistance Program 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5
... Chindex International, Inc. (NASDAQ: CHDX ), ... China through the operations of United Family Healthcare, a network ... announced financial results for the third quarter and first nine ... Third Quarter 2011 Financial Highlights ...
...  Inova Labs, a privately held medical ... Chronic Obstructive Pulmonary Disease (COPD) market, announced today that ... financing for up to $17.5M from an investment syndicate ... Calif. The company plans to use the capital to ...
Cached Medicine Technology:Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 2Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 3Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 4Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 5Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 6Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 7Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 8Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 9Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 10Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 11Inova Labs Closes on $17.5M Series B Financing 2
(Date:5/23/2015)... On May 16, the team at ... a 5k mud obstacle run that raised funds for multiple ... worldwide, and the reason we participated was to support people ... of Farrell’s eXtreme Bodyshaping. “One-hundred percent of the funds raised ... event was not only attended by eXtreme Bodyshaping staff, but ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 A live auction ... equipment from hospitals, surgery centers and other medical facilities around ... sold including endoscopy, lab, radiology, surgery, anesthesia, exam and much ... May 27 and Thursday, May 28 starting at 9:00am CDT ... at 1400 N. 25th Avenue, Melrose Park, IL 60160. ...
(Date:5/23/2015)... Add High-Quality prismatic refractions into footage using ProFlare ... simple as dragging and dropping footage into the FCPX timeline ... , Including over 80 stunning flares, ProFlare 5K Prism ... the ultimate bundle for adding prismatic refractions to any video. ... movie files designed for Final Cut Pro X, but are ...
(Date:5/22/2015)... May 22, 2015 The world ... and capacity are intersecting to create new opportunities ... the opening speaker at WesternU's 34th annual Commencement ... Gov. Gavin Newsom, a former San Francisco mayor ... speaker at the graduation ceremony for WesternU's colleges ...
(Date:5/22/2015)... 2015 The American College of Traditional ... June. They will hold a webinar on the updates ... class on Classical Chinese Medicine. , Webinar – First ... Given, the Dean of Clinical Education, will lead this ... Professional Doctorate program. ACTCM is currently developing this degree ...
Breaking Medicine News(10 mins):Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:ACTCM Announces Upcoming June Events 2
... with muscle-thickening disorder may also identify children at risk ... 10 gene mutations responsible for cardiac hypertrophy (thickening of ... many cases of this rare but life-threatening condition in ... showed up in children who had no family history ...
... Muneo Takashi has been,named to head the Chicago ... As the new Chief Executive Director, Takashi follows ... assignment in Chicago., As Chief Executive Director, ... activities designed to facilitate business development,between Japan and ...
... Tripled dose was ineffective and toxic, so strategy should ... News) -- High-intensity chemotherapy does not improve the survival ... a new Swiss study concludes. , Testing on 140 ... differences in survival rate or tumor size between groups ...
... Researchers at Boston College have developed the first laboratory ... Using their novel cell line, the team discovered one of ... attack. , The development of a new animal model ... that displays the full spectrum of systemic metastatic cancer ...
... remains,underdiagnosed and undertreated even though this neurologic ... options have increased in the,last decade., ... treat this neurologic,sleep disorder, The Journal of ... supplement "Stay awake! Understanding, diagnosing, and,successfully managing ...
... 9 United Heartland is pleased to,announce that ... of,Community Providers has earned a record dividend of ... performance of the group,s 48 members, which,achieved an ... http://www.newscom.com/cgi-bin/prnh/20080409/CLW076LOGO ), The Iowa Association of ...
Cached Medicine News:Health News:Gene Mutations for Rare Heart Disease Also Found in Kids 2Health News:Muneo Takashi Named Chief Executive Director of Japan's Midwest Trade Office 2Health News:High-Dose Chemo Fails Against Small Cell Lung Cancers 2Health News:Boston College biologists build a better mouse model for cancer research 2Health News:United Heartland Group Program Earns Record Dividend 2
Bailey lachrymal cannula, 7 mm exposed tip, 8 mm reinforced....
Lachrymal cannula, straight....
Shahinian lacrimal cannula, bullet shaped tip, 0.3 mm side opening, straight....
Solo-care is a multi-purpose solution for cleaning, rinsing, disinfection and storing soft contact lenses....
Medicine Products: